We are live on
!
Find out more
SSCM
Summit Street Capital Management Portfolio holdings
AUM
$707M
1-Year Est. Return
76.8%
This Fund
S&P 500
This Quarter
Est. Return
+4.02%
1 Year Est. Return
+76.8%
3 Year Est. Return
+144.33%
5 Year Est. Return
+200.14%
10 Year Est. Return
+704.53%
AUM
$156M
AUM Growth
+$1.98M
(+1.3%)
Cap. Flow
-$2.05M
Cap. Flow
% of AUM
-1.31%
Top 10 Holdings %
Top 10 Hldgs %
49.68%
Holding
33
New
–
Increased
4
Reduced
1
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Warner Bros
WBD
|
+$1.05M |
| 2 |
Gilead Sciences
GILD
|
+$855K |
| 3 |
Fox Class A
FOXA
|
+$710K |
| 4 |
TriNet
TNET
|
+$96.8K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Pacific Land
TPL
|
+$4.09M |
| 2 |
Westlake Corp
WLK
|
+$677K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.6% |
| 2 | Healthcare | 17.86% |
| 3 | Financials | 15.55% |
| 4 | Energy | 14.77% |
| 5 | Consumer Discretionary | 10.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Berkshire Hathaway Class A
BRK.A
$1.1T
| $24.3M | 15.55% |
58
| – | – |
|
2
United Therapeutics
UTHR
$26.3B
| $6.78M | 4.34% |
37,805
| – | – |
|
|
3
Texas Pacific Land
TPL
$27B
| $6.78M | 4.34% |
38,133
-23,490
| -38% | -$4.09M |
|
4
Elevance Health
ELV
$82.5B
| $6.2M | 3.97% |
16,235
| – | – |
|
5
HP
HPQ
$25.5B
| $5.87M | 3.76% |
194,315
| – | – |
|
6
Humana
HUM
$45.8B
| $5.85M | 3.75% |
13,221
| – | – |
|
7
Magna International
MGA
$18.7B
| $5.62M | 3.6% |
60,650
| – | – |
|
8
Valero Energy
VLO
$89B
| $5.5M | 3.52% |
70,422
| – | – |
|
9
LyondellBasell Industries
LYB
$19.2B
| $5.35M | 3.43% |
51,979
| – | – |
|
10
Marathon Petroleum
MPC
$90B
| $5.33M | 3.42% |
88,279
| – | – |
|
11
Molina Healthcare
MOH
$10.2B
| $5.25M | 3.36% |
20,746
| – | – |
|
|
TSE
12
DELISTED
Trinseo
TSE
| $5.08M | 3.26% |
84,963
| – | – |
|
13
HF Sinclair
DINO
$16.1B
| $4.95M | 3.17% |
150,369
| – | – |
|
14
Micron Technology
MU
$928B
| $4.85M | 3.1% |
57,042
| – | – |
|
15
Intel
INTC
$436B
| $4.8M | 3.08% |
85,583
| – | – |
|
|
16
TriNet
TNET
$3.13B
| $4.79M | 3.07% |
66,150
+1,249
| +2% | +$96.8K |
|
17
Medifast
MED
$109M
| $4.63M | 2.96% |
16,356
| – | – |
|
|
18
Warner Bros
WBD
$64.1B
| $4.59M | 2.94% |
149,641
+30,411
| +26% | +$1.05M |
|
19
Applied Materials
AMAT
$379B
| $4.46M | 2.86% |
31,342
| – | – |
|
20
InterDigital
IDCC
$6.77B
| $4.45M | 2.85% |
60,870
| – | – |
|
21
Kulicke & Soffa
KLIC
$4.71B
| $4.44M | 2.85% |
72,603
| – | – |
|
|
22
Gilead Sciences
GILD
$166B
| $3.8M | 2.44% |
55,227
+12,804
| +30% | +$855K |
|
23
Huntsman Corp
HUN
$2.05B
| $3.56M | 2.28% |
134,296
| – | – |
|
|
24
Fox Class A
FOXA
$24.3B
| $3.23M | 2.07% |
86,998
+18,931
| +28% | +$710K |
|
25
Lam Research
LRCX
$333B
| $3.19M | 2.04% |
49,030
| – | – |
|
Similar funds
NG
IFM
GHCMRT
AC
JPMIA
LSIA
DIA
SSP
Summit Street Capital Management's Q2 2021 Portfolio in Review
As of Q2 2021, Summit Street Capital Management held 33 positions worth $156M, up 1.3% from $154M the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Trading was light in Q2 2021: portfolio turnover was 3%. Summit Street Capital Management opened no new positions and exited 1, leaving the 33-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Summit Street Capital Management added most to Warner Bros in Q2 2021, an estimated $1.05M increase.
- Summit Street Capital Management's biggest Q2 2021 reduction was Texas Pacific Land, cutting an estimated $4.09M.
- Summit Street Capital Management fully exited Westlake Corp in Q2 2021, selling an estimated $677K.
- Summit Street Capital Management's ten largest holdings make up 50% of its $156M portfolio in Q2 2021.
- Summit Street Capital Management opened 0 new positions and closed 1 in Q2 2021.
- Summit Street Capital Management's portfolio value rose 1.3% quarter-over-quarter to $156M.
Based on Summit Street Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.